1 min read
BIOFLUX SYSTEM USED IN KEY STUDIES TO IDENTIFY CAUSES AND TREATMENTS OF BLOOD CLOTS RELATED TO COVID-19
Potential treatments identified that may offer improved outcomes in COVID-19 patients with increased thrombus formation
Alameda, Calif. -- Fluxion Biosciences announced two recent publications on COVID-19 and its ability to lead to high levels of platelet coagulation and an increased risk of thrombosis. The first study, published by a team at the University of Pennsylvania School of Medicine, was published in May 2021 as a preprint in bioRxiv, and is titled “Signaling through FcgRIIA and the...